L.L. Miller

Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.

Lynn E. S̄pitler, Maguy Del Rio, Archie Khentigan et al. · PubMed · 1987 · 215 citations

Medicine, Oncology, Pharmacology +11

Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis

Michael Wilschanski, L.L. Miller, David Shoseyov et al. · European Respiratory Journal · 2011 · 201 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies.

John W. Smith, Walter J. Urba, Brendan D. Curti et al. · Journal of Clinical Oncology · 1992 · 166 citations

Medicine, Oncology, Pharmacology +13

Multicenter, Phase II Trial of Exemestane as Third-Line Hormonal Therapy of Postmenopausal Women With Metastatic Breast Cancer

Stefanie A Jones, Charles L. Vogel, A. Arkhipov et al. · Journal of Clinical Oncology · 1999 · 113 citations

Medicine, Oncology, Pharmacology +17

Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy.

Henry C. Pitot, Richard M. Goldberg, Joel M. Reid et al. · PubMed · 2000 · 73 citations

Medicine, Oncology, Pharmacology +15